Condition: Atopic Dermatitis (Eczema) · Atopic Dermatitis Eczema · Atopic Dermatitis · Sponsor: Alphyn Biologics
A Phase 2b study investigating the efficacy of zabalafin in people with mild to moderate atopic dermatitis (eczema).
This description comes directly from the study's public registry record.
Dr. Lynda Spelman · +61730391311 · trials@veracityclinicalresearch.com.au
Always discuss trial participation with your own doctor first.
| Canopy Clinical Northern Beaches | Brookvale, New South Wales, Australia | Recruiting |
| Momentum Clinical Research | Darlinghurst, New South Wales, Australia | Recruiting |
| Premier Specialists | Kogarah, New South Wales, Australia | Recruiting |
| St George Dermatology | Kogarah, New South Wales, Australia | Recruiting |
| Novatrials | Kotara, New South Wales, Australia | Recruiting |
| Innovate Clinical Research | Waitara, New South Wales, Australia | Recruiting |
| Canopy Clinical Wollongong | Wollongong, New South Wales, Australia | Recruiting |
| The Skin Center | Benowa, Queensland, Australia | Recruiting |
| Momentum Clinical Research | Wellers Hill, Queensland, Australia | Recruiting |
| Veracity Clinical Research | Woolloongabba, Queensland, Australia | Recruiting |
| Canopy Clinical Altona North | North Altona, Victoria, Australia | Recruiting |
| Captain Stirling Medical Centre | Nedlands, Western Australia, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06855745